SCHEMBL26017882

SCHEMBL26017882

C=C(Nc1nnc(-c2cccs2)o1)c1ccc(S(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ADCY1 Q08828 4/20 0.60
▸ KDM4E B2RXH2 11/20 0.58
▸ SMN1; SMN2 Q16637 7/20 0.58
▸ HTT P42858 6/20 0.58
▸ LMNA P02545 6/20 0.58
▸ MEN1 O00255 6/20 0.54
▸ KMT2A Q03164 6/20 0.54
▸ ALDH1A1 P00352 4/20 0.52
▸ TDP1 Q9NUW8 5/20 0.52
▸ TP53 P04637 5/20 0.52
▸ USP2 O75604 4/20 0.52
▸ ALOX15 P16050 4/20 0.52
▸ TSHR P16473 1/20 0.52
▸ OPRK1 P41145 1/20 0.51
▸ POLB P06746 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ RECQL P46063 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21464953 0.88 ADCY1 (0.78) ADCY1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL20597939 0.75 ADCY1 (1.00) ADCY1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL21464807 0.75 ADCY1 (0.71) ADCY1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL21465001 0.73 KDM4E (0.74) ADCY1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL22594363 0.73 KDM4E (0.71) ADCY1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL22994218 0.72 ADCY1 (0.70) ADCY1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL22994222 0.72 ADCY1 (0.69) ADCY1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL22993988 0.71 ADCY1 (0.67) ADCY1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL22994220 0.71 ADCY1 (0.67) ADCY1KDM4ESMN1; SMN2HTTLMNA
SCHEMBL24146220 0.70 KDM4E (0.78) ADCY1KDM4ESMN1; SMN2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11731964-B2 Benzamide antibacterial agents PURDUE RESEARCH FOUNDATION (US) 2023-08-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11731964-B2 Benzamide antibacterial agents HDAC6, HDAC5, HDAC3 ADCY1 4465/4885KDM4E 1365/4885SMN1; SMN2 2845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback